{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-011752","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.585857+00:00","generated_at":"2026-05-17T10:14:33.290611+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NextCure CSO resigns effective Sept 1, 2025; no replacement named","bullets":["Solomon Langermann, Ph.D., resigned as Chief Scientific Officer, effective September 1, 2025.","Resignation was not due to any disagreement with the Company or its operations.","No successor has been announced at this time.","Board and Company thanked Dr. Langermann for his contributions."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-011752","json":"https://secwatch.observer/filing/0001558370-25-011752.json","markdown":"https://secwatch.observer/filing/0001558370-25-011752.md","text":"https://secwatch.observer/filing/0001558370-25-011752.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/0001558370-25-011752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/nxtc-20250821x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:14:33.290611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}